Global Burden of Urologic Cancers, 1990–2013

Slides:



Advertisements
Similar presentations
Early Detection of Prostate Cancer in 2007
Advertisements

Volume 72, Issue 1, Pages (July 2017)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Testosterone Therapy in Men With Prostate Cancer
Volume 63, Issue 5, Pages (May 2013)
Global Trends in Testicular Cancer Incidence and Mortality
Volume 70, Issue 6, Pages (December 2016)
Volume 62, Issue 5, Pages (November 2012)
The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks  Marcus G.
Volume 61, Issue 5, Pages (May 2012)
Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey  Varant Kupelian,
Volume 64, Issue 4, Pages (October 2013)
Volume 50, Issue 5, Pages (November 2006)
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment 
Let the Games Begin (with EAU Approval)
Prostate Cancer Epidemic in Sight?
Volume 72, Issue 5, Pages (November 2017)
Bladder Cancer: A Major Public Health Issue
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 68, Issue 5, Pages (November 2015)
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Prostate Cancer Detection: A View of the Future
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
Volume 67, Issue 3, Pages (March 2015)
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes  European Urology 
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 69, Issue 3, Pages (March 2016)
Shaheen Alanee, Kasmintan Schrader, Kenneth Offit  European Urology 
Volume 57, Issue 4, Pages e41-e42 (April 2010)
Volume 63, Issue 4, Pages (April 2013)
Volume 52, Issue 4, Pages (October 2007)
Prostate Cancer Epidemic in Sight?
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 68, Issue 6, Pages (December 2015)
Volume 61, Issue 2, Pages (February 2012)
Volume 62, Issue 4, Pages (October 2012)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Volume 63, Issue 3, Pages (March 2013)
Richard C. Harkaway  European Urology Supplements 
The Economic Costs of Overactive Bladder in Germany
Volume 50, Issue 3, Pages (September 2006)
Volume 50, Issue 5, Pages (November 2006)
Volume 58, Issue 3, Pages (September 2010)
Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, Jonas Hugosson
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Volume 72, Issue 4, Pages (October 2017)
Testicular Cancer Variations in Time and Space in Europe
Volume 53, Issue 1, Pages (January 2008)
Volume 68, Issue 1, Pages (July 2015)
Volume 59, Issue 4, Pages (April 2011)
Prognostic Impact of Comorbidity in Patients with Bladder Cancer
Volume 72, Issue 1, Pages (July 2017)
European Urology is “Your” Journal
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
Epidemiology of Renal Cell Carcinoma
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Economic Burden of Bladder Cancer Across the European Union
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Volume 54, Issue 3, Pages (September 2008)
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Epidemiology and Demographics of Prostatitis
Cancer epidemiology and trends in North Khorasan Province of Iran
Does PSA Testing Influence the Natural History of Prostate Cancer?
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Global Burden of Urologic Cancers, 1990–2013 Geolani W. Dy, John L. Gore, Mohammad H. Forouzanfar, Mohsen Naghavi, Christina Fitzmaurice  European Urology  Volume 71, Issue 3, Pages 437-446 (March 2017) DOI: 10.1016/j.eururo.2016.10.008 Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 1 Trends in age-standardized incidence and death rates by development status for (A) kidney cancer, women and men; (B) bladder cancer, women and men; (C) prostate cancer, 1990–2013. ASDR=age-standardized death rates; ASIR age-standardized incidence rates. European Urology 2017 71, 437-446DOI: (10.1016/j.eururo.2016.10.008) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 2 Cancer deaths. (A) Proportion of kidney cancer deaths attributable to risk factors by sex and development status in all ages, 1990 and 2013. (B) Proportion of bladder cancer deaths attributable to risk factors by sex and development status in all ages, 1990 and 2013. BMI=body mass index. European Urology 2017 71, 437-446DOI: (10.1016/j.eururo.2016.10.008) Copyright © 2016 European Association of Urology Terms and Conditions